Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse beta Catenin ELISA Kit (AC2628)
Cat.#: ASET-1217
Specifications
Description Mouse beta Catenin ELISA Kit allows for the in vitro quantitative determination of mouse beta Catenin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1683 Human NOX3 ELISA Kit (AC3094) Quantitative inquiry ASET-2387 Human Dynamin 1 ELISA Kit (AC3798) Quantitative inquiry ASET-2397 Human Gigaxonin ELISA Kit (AC3808) Quantitative inquiry ASET-1621 Mouse PPAR gamma ELISA Kit (AC3032) Quantitative inquiry ASET-2414 Human TGFBI ELISA Kit (AC3825) Quantitative inquiry ASET-2114 Human SPON2 ELISA Kit (AC3525) Quantitative inquiry ASET-1223 Mouse Gprin1 ELISA Kit (AC2634) Quantitative inquiry ASET-1088 Mouse NMDAR2B ELISA Kit (AC2499) Quantitative inquiry ASET-2102 Human Ferritin Light Chain ELISA Kit (AC3513) Quantitative inquiry ASET-1575 Human KCNK9 ELISA Kit (AC2986) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket